Document Detail

After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
MedLine Citation:
PMID:  15062747     Owner:  NLM     Status:  MEDLINE    
Minimal doses of i.v. anti-D for ITP are not exempt from the risk of intravascular hemolysis, a rare potentially severe short-lived post-infusion complication. We report here on an elderly woman with chronic pancytopenia and splenomegaly in whom bleeding manifestations ceased after i.v. anti-Rh(D) immunoglobulin minidoses replaced long-term conventional treatment for immune thrombocytopenic purpura. Anti-Rh(D) infusions, that had been well tolerated for eight years, became the main culprit in triggering of disproportionate hemolysis. In spite of in crescendo complication, the anti-Rh(D) immunoglobulin schedule was maintained for another six months. With no further treatment, the patient's health remains stable 20 months later.
M D Enrique Rewald; M M Francischetti
Related Documents :
19729517 - The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: ...
24506577 - Rapid resolution of graft-versus-host-disease-related central serous chorioretinopathy.
20191207 - Neurobrucellosis: a rare cause for spastic paraparesis.
15457387 - Long-term outcome after laparoscopic splenectomy related to hematologic diagnosis.
17298307 - A randomised controlled trial of routine suction drainage after elective thyroid and pa...
20135077 - Antithrombotic treatment and the risk of death and stroke in patients with atrial fibri...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis     Volume:  30     ISSN:  1473-0502     ISO Abbreviation:  Transfus. Apher. Sci.     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2004-04-05     Completed Date:  2004-11-19     Revised Date:  2006-06-07    
Medline Journal Info:
Nlm Unique ID:  101095653     Medline TA:  Transfus Apher Sci     Country:  England    
Other Details:
Languages:  eng     Pagination:  105-10     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Infusions, Intravenous
Isoantibodies / administration & dosage*
Platelet Count
Purpura, Thrombocytopenic, Idiopathic / blood*,  immunology*
Rho(D) Immune Globulin / administration & dosage*,  adverse effects*
Time Factors
Reg. No./Substance:
0/Isoantibodies; 0/RHO(D) antibody; 0/Rho(D) Immune Globulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recruitment of voluntary non-remunerated apheresis donors: the second five years' experience in Shen...
Next Document:  GB virus C/hepatitis G virus infection in Indian blood donors and high-risk groups.